healthcare-thumbnail.png

3D Bioprinting Market - By Component (3D Bioprinters, Bioinks) By Technology (Magnetic Levitation, Inkjet-based, Syringe-based, Laser-based, Others), By Region, and by Segment Forecasts, 2023-2028

Global 3D Bioprinting Market (2023 - 2028)

The Global 3D Bioprinting Market size is estimated to grow from USD 2.3 Billion in 2023 to USD 8.4 Billion by 2028. The market is witnessing a healthy CAGR of 13.3 % from 2023 to 2028. The increased usage healthcare sector is the major factor that is driving the growth of the industry.

Industry Overview:

3D bioprinting is used to graph medical devices. Leading medical systems and pharmaceutical manufacturing agencies are focusing on enhancing their product portfolio throughout the world. The demand in this market is predicted to surge in response to the lack of organ donors in enough number. With research and improvement (R&D) funding inside medical devices poised to rise significantly, the market will attain growing boom possibilities in the coming years. A 3D bioprinting enterprise used different biomaterials technology and its laser printer, the U-FAB, to assemble a pulmonary epithelial model.

Most of the respiratory machine is lined with a sort of tissue known as the respiratory epithelial. This epithelial serves as a defense in opposition to illnesses and different objects. However, the resource of the mucociliary elevators additionally guards in opposition to infections and tissue damage. Consequently, it is anticipated that the enterprise for bioprinting would amplify as a result of rising cases of wish for these respiratory epithelial models.

The growing aging population throughout the world is predicted to force the demand for orthopedic implants, as the threat of peripheral vascular disease, diabetes-related gangrene cases, and osteoarthritis is greater among aged individuals. These factors are estimated to drive the growth of the market during the forecast period 2023-2028.

COVID-19 impact on the 3D Bioprinting Market   

COVID-19 is an infectious ailment caused by the novel coronavirus. Largely unknown before the outbreak started out in Wuhan (China) in December 2019, COVID-19 modified into an international pandemic in no time. The COVID-19 pandemic has expanded the burden on healthcare structures throughout the globe. Companies scaled up R&D efforts to advance vaccines and drugs in opposition to the virus. Vaccine-related research things to do in pharmaceutical and biotechnology companies, research centers, and tutorial lookup institutes are viewed as essential and generally unaffected operations and output. However, niche markets had been sidelined due to the center of attention on COVID treatment-related research.

3D bioprinting was once one such market. Thus, it experienced a barely bad impact. With the COVID-19 infection's fast expansion, 3D bioprinting is experiencing excessive demand. As a result, a lot of biopharmaceutical and pharmaceutical corporations are stepping up to support medical professionals, doctors, and researchers in something manner they can. As the instances of COVID-19 are growing day by day, there has been a scarcity of materials for clinical professionals as properly as for the general public. One of the largest issues is the lack of availability of check kits for COVID-19.

MARKET DRIVERS:

The increased usage healthcare sector is driving the growth of the market

There has been an expanded demand for 3D bioprinting in the healthcare sector around the world. These options are used for the improvement of organs and the building of tissues, which are in addition used to boost medical implants and for R&D activities associated with drugs. The 3D bioprinting market is at an embryonic stage and this is used to generate a substitute for human tissue, which is estimated to result in a pioneer in the healthcare or scientific vertical.

The technology is used for correct and fast drug testing due to its capability to check workable drug compounds on printed tissues earlier than being used on human beings. These factors are estimated to drive the growth of the market.

MARKET RESTRAINTS:

The High cost and time taking procedures are restraining the growth of the market

The lack of physical properties is restraining the growth of the market during the forecast period. The main drawback of auxetic materials is that sometimes they are too much porous and not dense enough for load bearing which reduces their capability to hold the hold and also creates a restrain in the growth of the market.

This research report on the global 3D Bioprinting Market has been segmented and sub-segmented based on Material Structure, and region.

Global 3D Bioprinting Market   - By Component:

  • 3D Bioprinters
  • Bio inks 

Based on the component, the 3D Bioprinters segment is estimated to dominate the market. The most frequent utility of 3D bioprinting in healthcare is to regenerate tissues and organs appropriate for transplant. The want for organ and tissue manufacturing is growing as COVID-19 disorder instances rise. The organ and tissue production phase are envisioned to trip explosive growth for the duration of the projected duration as a result. The most important market participants expect that the rising variety of COVID-19 instances in the world will open up new increase opportunities. New strategies are being developed with the aid of several 3D bioprinting market contributors to avoid this epidemic effect and create a COVID-19 vaccine.

Global 3D Bioprinting Market   - By Technology:

  • Magnetic Levitation
  • Inkjet-based
  • Syringe-based
  • Laser-based
  • Others

Based on the technology, The Inkjet based technology is estimated to dominate the market during the forecast period 2023-2028. The widespread use of inkjet printing in the healthcare enterprise is a factor in the growth of this market. In particular, the topics of biochemical regeneration and drug transport costs, and inkjet printing as a bio-applicable method are protected in this study. Because of its larger sturdiness and growing demands, this market area is anticipated to experience large enlargement during the projected timeframe. With its sophisticated features, multiplied speed, and improved accuracy, the magnetically levitated approach is predicted to put off greater than 80% of the errors in 3D bioprinting. Additionally, toxicity testing, the printing of vascular muscles, and proper tissue restoration all use these bioprinters.

Global 3D Bioprinting  Market  - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East
  • Africa

Geographically, North America is predicted to keep a dominating position in the world market over the coming years. The dominance of the area is attributed to the improved remember of the target population in North America. The presence of key players and the availability of sophisticated healthcare infrastructure in the location is additionally envisioned to propel the increased possibilities in the North American 3D bioprinting market. In addition, improved investments through regional players in special R&D activities are additionally estimated to make a contribution to growth possibilities in the market over the coming years.

With a universal income of 24.5% in the 3D printing technology market in Asia-Pacific in 2022, the area is projected to preserve its lead at some stage in the forecast timeframe. Due to the increasing variety of COVID-19 cases and multiplied government R&D spending, China and Japan contributed to the biggest basic income in the area.

The market in Europe is anticipated to extend at a low boom rate. However, product launches and capability expansion by a range of producers are predicted to improve the demand for auxetic substances in these regions

Global 3D Bioprinting Market Share by Company

Companies like Advanced Biomatrix, 3D Biotek, 3D Systems, Avita Medical, Bespoke Innovations, Autodesk, EnvisionTEC, Cyfuse Biomedical, CMC Microsystems, Digilab, United Therapeutics, TeVido BioDevices, DTM, Bio3D Technologies, Helisys Inc. CMC Microsystems, InSphero AG, and BD Biosciences, among others. and others play a pivotal role in the market. Mergers and acquisitions in the enterprise have enabled players to diversify and decorate their carrier services.

Recently, The BIO CELLX, a revolutionary technology that automates 3D cell cultivation processes by utilizing prevalidated procedures, was introduced by BICO Company AB (USA) in Mar 2022.

Leading players in the market are engaged in product innovation, lookup and improvement activities, and product launches and approval to preserve their position towards their competitors. Apart from players, quite a number of institutions are additionally engaged in 3D bioprinting R&D. The market at existing has 14 enterprise subsidized bioprinters, targeted on a range of business applications. The wide supply-demand gap for organ transplants is an unmet need; the final aim of researchers is to be in a position to create bio printed organs for organ transplants.

The market of 3D bioprinting especially focuses on industrial bioprinters and these under development, their functions, and the predicted future evolution. It is extensively expected that the 3D bioprinting market has super potential. It requires biocompatible substances (bio-ink and bio-paper), software programs (CAD), and hardware (bioprinters); each has the functionality to develop into separate areas in industries.

NOTABLE HAPPENINGS IN THE GLOBAL 3D BIOPRINTING MARKET IN THE RECENT PAST:

Product Launch - In March 2022, BICO Group AB (US) launched BIO CELLX, a novel system used to automate the workflow of 3D cell culture by leveraging prevalidated protocols.

 

 

Chapter 1. 3D BIOPRINTING MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. 3D BIOPRINTING MARKET – Executive Summary

2.1. Market Size & Forecast – (2022 – 2026) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-16 Impact Analysis

 2.3.1. Impact during 2022 - 2026

  2.3.2. Impact on Supply – Demand

Chapter 3. 3D BIOPRINTING MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. 3D BIOPRINTING MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. 3D BIOPRINTING MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. 3D BIOPRINTING MARKET – By Componet

6.1. 3D Bio printers

6.2. Bio Inks

Chapter 7. 3D BIOPRINTING MARKET – By Technology

7.1. Magnetic Leviation

7.2. Ink-Jet Based

7.3. Syringe Based

7.4. laser-based

7.5. Others

Chapter 8. 3D BIOPRINTING MARKET – By Region

8.1. North America

8.2. Europe

8.3. Asia-P2acific

8.4. Latin America

8.5. The Middle East

8.6. Africa

Chapter 9. 3D BIOPRINTING MARKET – By Companies

9.1. Advanced Biomatrix

9.2. 3D Biotek

9.3. 3D Systems

9.4. Avita Medical

9.5. Bespoke Innovations

9.6. Autodesk

9.7. Envision TEC

9.8. Cyfuse Biomedical

9.9. CMC Microsystems

9.10. Digilab United Therapeutics

9.11. TeVido Biodevices

9.12. DTM

9.13. Bio 3D Technologies

9.14.Helisys Inc

9.15. CMC Microsystems

9.16. Insphereo AG

9.17. BD Biosciences

 

Download Sample

The field with (*) is required.

Choose License Type

$

2500

$

4250

$

5250

$

6900

Frequently Asked Questions

The Global 3D Bioprinting Market was estimated at USD 2.3 Billion in 2023 and is anticipated to be a value of USD 8.4 Billion by 2028, growing at a fast CAGR of 13.3 % during the forecast period 2023-2028.

 

The Global 3D Bioprinting Market drives various usage in healthcare industries for various diseases.

 

The Segments under the Global 3D Bioprinting Market by Technology are Magnetic Levitation, Inkjet-based, Syringe-based, Laser-based, and Others.

 

USA is the most dominating country in the North American region for the Global 3D Bioprinting Market.

 

Advanced Biomatrix, 3D Biotek, and 3D Systems, are the leading players in the Global 3D Bioprinting Market.

 

Analyst Support

Every order comes with Analyst Support

Customization

We offer customization to cater your needs to fullest

Verified Analysis

We value Integrity, quality and authenticity the most